NewCelase®GMPForAdiposeStemCellIsolation

Worthingtonnowoffersanotherpotentialsolutionforyouradiposestemcellisolationapplications;Celase®GMP,anavianandmammaliantissue-freeCollagenaseandneutralproteaseenzymeblendproducedunderGMPqualityconditionsbyCytoriTherapeutics,aleaderinthedevelopmentofhumanadiposestemcellisolationtherapiesforclinicalapplications.

Celase®GMPisspecificallydesignedforstemcellisolationfromhumanandotheradiposetissuewithfollowingadvantages:

•Asingle,sterile,ready-to-usevialcontainingbothcollagenaseandneutralproteasecandigestupto280g ofadiposetissuewithbest-in-classGMPqualityandshelflifeofupto72months.

•CurrentlyincludedinIDEapplicationsapprovedbytheU.S.FDAforalopecia,chronicheartfailure,hamstringinjuries,osteoarthritisoftheknee,andhandmanifestationsofscleroderma.

•ATechnicalDossierisavailablefromCytoritoeasethetransitionfromresearchtoclinicalapplications.

•ResearchprotocolsareavailablefromWorthingtonandCytorifordissociatingcanine,equine,human,ovine,porcine,rabbitandrodentadiposetissue.

•Aproprietary,blendedproteolyticenzymedesignedforefficient,gentleandreproducibleinvitrodissociationofnucleatedcellsfromadiposetissue.

•Producedusingavianandmammaliantissue-freerawmaterials,asepticprocessesandsterilefiltrationunder GMPguidelinestoassurethelowestlevelsofimpuritiesandstringentqualitystandards.